104127-6

LOINC 2.82

Cytokeratin 19 mRNA for cancer metastasis [Presence] in Lymph node by NAA with non-probe detection

CK19 mRNA metastasis LN Ql NAA+n-prb

Component

  • Cytokeratin 19 mRNA for cancer metastasis

Specimen / system

  • Lymph node

Class

  • PATH

Property

  • PrThr

Scale

  • Ord

Method

  • Non-probe.amp.tar

Related names

  • 3 Self-Sustaining Sequence Replication; 3SR SR; Amplif; Amplification; Amplified; Autoimmune hepatitis; CK; CK 19; CK19; CK-19; CK19 mRNA metastasis; Cyfra 21-1; DNA NUCLEIC ACID PROBE; DNA probe; Keratin 19; Keratin, type I cytoskeletal 19; keratin-19 (K19); LAT; LCR; Ligase chain reaction; Ligation-activated transcription; Ln; Metastases; Mets; NAA+n-prb; NAA+probe; NAAT; NASBA; Nucleic acid sequence based analysis; Ordinal; PATHOLOGY; PCR; Point in time; Polymerase chain reaction; PR; Probe amp; Probe with ampification; Probe with target amplification; QBR; QL; Qual; Qualitative; Random; Screen; SDA; Strand Displacement Amplification; TMA; Transcription mediated amplification

Index terms

  • 3 Self-Sustaining Sequence Replication
  • 3SR SR
  • Amplif
  • Amplification
  • Amplified
  • Autoimmune hepatitis
  • CK
  • CK 19
  • CK-19
  • CK19
  • CK19 mRNA metastasis
  • Cyfra 21-1
  • DNA NUCLEIC ACID PROBE
  • DNA probe
  • Keratin 19
  • Keratin, type I cytoskeletal 19
  • keratin-19 (K19)
  • LAT
  • LCR
  • Ligase chain reaction
  • Ligation-activated transcription
  • Ln
  • Metastases
  • Mets
  • NAA+n-prb
  • NAA+probe
  • NAAT
  • NASBA
  • Nucleic acid sequence based analysis
  • Ordinal
  • PATHOLOGY
  • PCR
  • Point in time
  • Polymerase chain reaction
  • PR
  • Probe amp
  • Probe with ampification
  • Probe with target amplification
  • QBR
  • QL

8 further terms